2. 筋萎縮性側索硬化症 Amyotrophic lateral sclerosis Clinical trials / Disease details

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03427086 (ClinicalTrials.gov)	January 29, 2018	29/1/2018	Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis	Safety and Tolerability of High Dose Biotin in Patients With Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	Drug: Biotin;Drug: Placebo Oral Tablet	American University of Beirut Medical Center	NULL	Completed	18 Years	80 Years	All	12	Phase 2	Lebanon
2	EUCTR2015-005810-31-FR (EUCTR)	03/06/2016	24/10/2016	Effect of MD1003 in amyotrophic lateral sclerosis: a randomized, double blind placebo controlled stu ...	Effect of MD1003 in amyotrophic lateral sclerosis: a randomized, double blind placebo controlled stu ...	Amyotrophic lateral sclerosis MedDRA version: 19.0;Level: PT;Classification code 10002026;Term: Amyo ...	Product Code: MD1003 INN or Proposed INN: BIOTIN	MEDDAY PHARMACEUTICALS	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	France

First Previous1Next Last